VX-950

Telaprevir · Vertex Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VX-950, covering 2007-12-21 to 2011-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C [Phase 2]